Back to search
Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Transfusion Dependent Beta-Thalassemia (NTDT) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Transfusion Dependent Beta-Thalassemia (NTDT) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary purpose of this study was to compare the effect of mitapivat versus placebo on hemolytic anemia in participants with alpha- or beta-non-transfusion…
This study is researching an experimental drug called REGN7999 (called "study drug"). The study is focused on patients with non-transfusion dependent beta-thala…
This is a Phase 2, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept (ACE-536) versus placebo…
An open-label study in which 6 patients will receive once-weekly subcutaneous injections of EPEG for 4 weeks. Final visit will occur 60 days after study entry